Innovative Medical released its performance for the first three quarters, with a net profit attributable to the parent company of 4.7244 million yuan, a year-on-year increase of 116.97%
According to the Zhitong Finance APP, Innovative Medical released its third-quarter report for 2025. In the first three quarters, the company achieved operating revenue of 597 million yuan, a year-on-year decrease of 2.11%. The net profit attributable to shareholders of the listed company was 4.7244 million yuan, a year-on-year increase of 116.97%. The net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 29.4698 million yuan
According to the Zhitong Finance APP, Innovative Medical (002173.SZ) released its third-quarter report for 2025. In the first three quarters, the company achieved an operating income of 597 million yuan, a year-on-year decrease of 2.11%. The net profit attributable to shareholders of the listed company was 4.7244 million yuan, a year-on-year increase of 116.97%. The net loss attributable to shareholders of the listed company, after deducting non-recurring gains and losses, was 29.4698 million yuan
